Login / Signup

Developing a gateway program for importing non-animal origin ingredients from regions with African swine fever virus.

Olivia L HarrisonJordan T GebhardtChad B PaulkJason C WoodworthCassandra K Jones
Published in: Transboundary and emerging diseases (2022)
The US Department of Agriculture (USDA) categorizes the risk of African swine fever virus (ASFV) entry into the United States through non-animal origin feed ingredients as 'negligible to moderate, with high uncertainty'. Both Canada and Australia have implemented policies that are suggested to reduce the risk of ASFV entry through feed ingredients, but the United States has not because of scientific limitations that have been addressed by recent publications. As regulators and industry consider a potential pathway forward, the objective of this manuscript is to describe a process to determine if a voluntary or regulatory import policy is warranted by the United States. Initially, the volume and types of non-animal origin feed ingredients imported from countries with ASFV were quantified and assigned a level of risk (high risk: unprocessed grains and oilseeds, moderate risk: soybean co-products (meals, oil, and oilcake), and low risk: amino acids, vitamins, and other synthetically produced products from countries that have ASFV). In 2020, moderate- and high-risk ingredients from ASFV-positive countries represented 3.1% of all ingredients imported into the United States. Policies from Canada and Australia were evaluated for practicality of implementation by US government officials. Industry representatives from both countries consistently stated their policies would not be feasible in the United States due to the differences in cost and complexity of the swine and feed industries. Overall, unprocessed, or high-risk, ingredients from ASFV-positive countries represent a low percentage of imported ingredients into the United States; however, cautionary procedures may still be warranted given industry demand.
Keyphrases
  • public health
  • healthcare
  • primary care
  • high intensity
  • transcription factor
  • climate change
  • tertiary care